FindTrial
Sign In

Effects of cardiac rehabilitation on inflammation

Effects of acute and chronic aerobic exercise training on vascular and systemic inflammatory biomarkers in patients with coronary artery disease after revascularization interventions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201610085136N3
Enrollment
70
Registered
2017-05-04
Start date
2016-10-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases of the circulatory system. Ischaemic heart diseases

Interventions

Intervention 1: Intervention Group: . The cardiac rehabilitation comprise 24 sessions of exercise, schedule over 8 weeks in the Cardiac Rehabilitation Center of SHahid Beheshti Hospital (Kashan, Iran
Rehabilitation
Control group: patients in this group will have their ordinary medications, and life style.
Intervention Group: . The cardiac rehabilitation comprise 24 sessions of exercise, schedule over 8 weeks in the Cardiac Rehabilitation Center of SHahid Beheshti Hospital (Kashan, Iran). Each session

Sponsors

Vice Chancellor Of Research Kashan University of Medical Sciences
Lead Sponsor
Vice Chancellor Of Research Mohaghegh Ardebili University
Collaborator

Eligibility

Sex/Gender
Male
Age
35 Years to 65 Years

Inclusion criteria

Inclusion criteria: Exclusion criteria: Patients were excluded if they have congestive failure; immnomodulatory or anti-inflammatory medications other than Aspirin; or known history of immune related disorders; unstable angina; resting systolic blood pressure >200 mmhg or diastolic blood pressure>10mmhg; uncontrolled bradycardia or tachycardia. Inclusion criteria:history of CABG and PCI; have ability to present in cardiac rehabilitation program; not having any physical exercise out of cardiac rehabilitation program; cardiac rehabilitation start 2 month after CABG and 1 month after PCI

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
PTX3. Timepoint: before and 30 min after one session submaximal aerobic exercise, and after 8 weeks cardiac rehabilitation program. Method of measurement: Human Pentraxin 3 Elisa Kit 96t - Zellbio Germany.;VCAM-1. Timepoint: before and 30 min after one session submaximal aerobic exercise, and after 8 weeks cardiac rehabilitation program. Method of measurement: Human VCAM-1 Elisa Kit 96t - Diaclone France.;CRP. Timepoint: before and 30 min after one session submaximal aerobic exercise, and after 8 weeks cardiac rehabilitation program. Method of measurement: Pars Azmon kit.—

Secondary

MeasureTime frame
Weight. Timepoint: before and after intervention. Method of measurement: balance scales.;Body mass index. Timepoint: before and after intervention. Method of measurement: weight divided by height square(kg/m2).;Fasting blood glucose. Timepoint: before and after intervention. Method of measurement: blood analysis.;Blood pressure. Timepoint: before and after intervention. Method of measurement: sphygmomanometer.;Total cholestrol. Timepoint: before and after intervention. Method of measurement: blood analysis.;HDL- cholestrol. Timepoint: before and after intervention. Method of measurement: blood analysis.;LDL-cholestrol. Timepoint: before and after intervention. Method of measurement: blood analysis.;Triglyceride. Timepoint: before and after intervention. Method of measurement: blood analysis.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Basati

Mohaghagh Ardebili University

basatifatemeh@yahoo.com; fatemeh.basati1987@gmail.com+98 21 2298 9007

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026